tirzepatide and glp 1 The dual agonist action of on various organs. GLP-1: Troubling Findings in Study of

This blog explores a presentation at the medical conference of Digestive Disease Week 2024 in Washington

Mounjaro is a once-weekly injection in the tummy, thigh, or upper arm The dose is started low and increased gradually to reduce side effects It is used alongside a reduced-calorie diet and increased physical activity for best results Mounjaro is started at a low initial dose to help minimise side effects, particularly gastrointestinal symptoms such as nausea

For more information on effective weight management strategies, you might find our article on Unlocking Weight Loss Success helpful

Serious but less common risks may include: Pancreatitis Gallbladder disease Severe dehydration Thyroid tumor warnings in animal studies Patients should always discuss personal medical history and risks with a qualified healthcare provider before starting treatment

Always consult with your rheumatologist or GP before starting any new medication